Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven TreatmentHemic and Lymphatic Diseases, Neoplasms by Histologic Type, Nutritional and Metabolic Diseases, Precursor Cell Lymphoblastic Leukemia-Lymphoma, childhood acute lymphoblastic leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm, nutritional deficiency disease, nutritional disorderRecruitingNot stated2026-08-14NCT06274788

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Fresenius Kabi7

10 results · Page 1 of 1

Swipe the table sideways for more columns.